Results 101 to 110 of about 71,360 (115)

The rapamycin analog CCI-779 is a potent inhibitor of pancreatic cancer cell proliferation

Biochemical and Biophysical Research Communications, 2005
Donghui Li
exaly  

Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugs

Investigational New Drugs, 2004
John Kuhn, Patrick Y Wen, David Schiff
exaly  

Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme

Investigational New Drugs, 2005
Patrick Y Wen, Charles Conrad, Karen Fink   +2 more
exaly  

Acyl-peptide releasing enzyme from Sulfolobus tokodaii (ST0779) as a novel promiscuous biocatalyst for aldol addition

Catalysis Communications, 2015
Bianca Perez, Hui Jian, Renjun Gao
exaly  

Characterization and mechanism insight of accelerated catalytic promiscuity of Sulfolobus tokodaii (ST0779) peptidase for aldol addition reaction

Applied Microbiology and Biotechnology, 2015
Jingbo Li, Bianca Perez, Hui Jian
exaly  

Convenient efficient synthesis of TAK-779, a nonpeptide CCR5 antagonist: development of preparation of various ammonium salts using trialkylphosphite and N-halogenosuccinimide

Tetrahedron, 2001
Tomomi Ikemoto, Atsuko Nishiguchi, Kiminori Tomimatsu   +2 more
exaly  

Randomized Phase II Study of Multiple Dose Levels of CCI-779, a Novel Mammalian Target of Rapamycin Kinase Inhibitor, in Patients With Advanced Refractory Renal Cell Carcinoma

Journal of Clinical Oncology, 2004
Michael B Atkins, Manuel Hidalgo, Janice P Dutcher   +2 more
exaly  

In vivo antitumor effect of the mTOR inhibitor CCI-779 and gemcitabine in xenograft models of human pancreatic cancer

International Journal of Cancer, 2006
Tomohiko Mori, Kazuhiro Kami, Masayuki Koizumi   +2 more
exaly  

Comparison of radiosensitizing effects of the mammalian target of rapamycin inhibitor CCI-779 to cisplatin in experimental models of head and neck squamous cell carcinoma

Molecular Cancer Therapeutics, 2009
Oleksandr Ekshyyan, Xiaohua Rong, Fleurette Abreo   +2 more
exaly  

Effect of HTI–286 and CCI–779 alone and in combination on hepatic tumour cell proliferation

Zeitschrift Fur Gastroenterologie, 2006
Y Vashist
exaly